Product Categories
Country: | China |
---|---|
Tel: | 020-82000279 |
Mobile: | 18024082417 |
E-mail: | |
QQ: | |
Skype: | Chat Now! |
Product Name | MF | CAS | Details |
---|
SLV-2436 | C19H15ClN4O | 2095704-43-9 | Details |
KO-947 | C21H17N5O | 1695533-89-1 | Details |
UM-164 | C30H31F3N8O3S | 903564-48-7 | Details |
ERK1/2 inhibitor 1 | C29H32ClN5O4 | 2095719-90-5 | Details |
GW806742X | C25H22F3N7O4S | 579515-63-2 | Details |
MK-2 Inhibitor III | C21H18N4O2 | 1186648-22-5 | Details |
CC-90003 | C22H21F3N6O2 | 1621999-82-3 | Details |
GW284543 | C23H20N2O3 | 790186-68-4 | Details |
DLK-IN-1 | C20H24F3N5O2 | 1620574-24-4 | Details |
p38α inhibitor 1 | C22H26F2N4O2 | 1034189-82-6 | Details |
AZ304 | C27H25N5O2 | 942507-42-8 | Details |
(rel)-AR234960 | C27H30FN5O5S | 1408311-94-3 | Details |
MW-150 | C24H23N5 | 1628502-91-9 | Details |
JNK Inhibitor VIII | C18H20N4O4 | 894804-07-0 | Details |
IQ-3 | C20H11N3O3 | 312538-03-7 | Details |
Guggulsterone | C21H28O2 | 95975-55-6 | Details |
BI-882370 | C28H33F2N7O2S | 1392429-79-6 | Details |
WHI-P258 | C16H15N3O2 | 21561-09-1 | Details |
CMPD1 | C22H20FNO2 | 41179-33-3 | Details |
Belvarafenib | C23H16ClFN6OS | 1446113-23-0 | Details |
SB-590885 | C27H27N5O2 | 405554-55-4 | Details |
Trametinib | C26H23FIN5O4 | 871700-17-3 | Details |
Trametinib (DMSO solvate) | C28H29FIN5O5S | 1187431-43-1 | Details |
AZ 628 | C27H25N5O2 | 878739-06-1 | Details |
AS601245 | C20H16N6S | 345987-15-7 | Details |
Pluripotin | C27H25F3N8O2 | 839707-37-8 | Details |
5,6,7-Trimethoxyflavone | C18H16O5 | 973-67-1 | Details |
MK-8353 | C37H41N9O3S | 1184173-73-6 | Details |
AZD-0364 | C24H24F2N8O2 | 2097416-76-5 | Details |
PROTAC B-Raf degrader 1 | C36H37N5O12S | 2364367-27-9 | Details |
LUT014 | C27H19F3N8O | 2274819-46-2 | Details |
BAY885 | C25H28F3N7O2 | 2307249-33-6 | Details |
5Z-7-Oxozeaenol | C19H22O7 | 253863-19-3 | Details |
SR-3306 | C28H26N8O | 1128096-91-2 | Details |
ERK5-IN-2 | C17H11BrFN3O2 | 1888305-96-1 | Details |
p38 MAPK-IN-1 | C21H14F2N2O | 1006378-90-0 | Details |
CC-401 hydrochloride | C22H25ClN6O | 1438391-30-0 | Details |
Cobimetinib racemate | C21H21F3IN3O2 | 934662-91-6 | Details |
Regorafenib Hydrochloride | C21H16Cl2F4N4O3 | 835621-07-3 | Details |
JNK-IN-8 | C29H29N7O2 | 1410880-22-6 | Details |
ZM 336372 | C23H23N3O3 | 208260-29-1 | Details |
TAK-733 | C17H15F2IN4O4 | 1035555-63-5 | Details |
TBAP-001 | C27H23F2N7O3 | 1777832-90-2 | Details |
U0126-EtOH | C20H22N6OS2 | 1173097-76-1 | Details |
Pimasertib | C15H15FIN3O3 | 1236699-92-5 | Details |
BIX02188 | C25H24N4O2 | 334949-59-6 | Details |
BIX02189 | C27H28N4O2 | 1265916-41-3 | Details |
AZD8330 | C16H17FIN3O4 | 869357-68-6 | Details |
AT7867 | C20H20ClN3 | 857531-00-1 | Details |
AT7867 dihydrochloride | C20H21Cl2N3 | 1431697-86-7 | Details |
PD318088 | C16H13BrF3IN2O4 | 391210-00-7 | Details |
FR 180204 | C18H13N7 | 865362-74-9 | Details |
HG6-64-1 | C32H34F3N5O2 | 1315329-43-1 | Details |
KY-05009 | C18H16N4O2S | 1228280-29-2 | Details |
LY-2584702 tosylate salt | C28H27F4N7O3S | 1082949-68-5 | Details |
LY3009120 | C23H29FN6O | 1454682-72-4 | Details |
B-Raf inhibitor 1 | C26H19ClN8 | 1093100-40-3 | Details |
VX-11e | C24H20Cl2FN5O2 | 896720-20-0 | Details |
BMS-582949 hydrochloride | C22H27ClN6O2 | 912806-16-7 | Details |
GSK-25 | C24H16Cl2F2N6O | 874119-56-9 | Details |
ERK5-IN-1 | C25H29N7O2 | 1234479-76-5 | Details |
Dabrafenib | C23H20F3N5O2S2 | 1195765-45-7 | Details |
Dabrafenib Mesylate | C24H24F3N5O5S3 | 1195768-06-9 | Details |
Refametinib | C19H20F3IN2O5S | 923032-37-5 | Details |
RO4987655 | C20H19F3IN3O5 | 874101-00-5 | Details |
Bentamapimod | C25H23N5O2S | 848344-36-5 | Details |
Agerafenib | C24H22F3N5O5 | 1188910-76-0 | Details |
SL 0101-1 | C25H24O12 | 77307-50-7 | Details |
TAK-580 | C17H12Cl2F3N7O2S | 1096708-71-2 | Details |
NG25 | C29H30F3N5O2 | 1315355-93-1 | Details |
Encorafenib | C22H27ClFN7O4S | 1269440-17-6 | Details |
Tanzisertib | C21H23F3N6O2 | 899805-25-5 | Details |
RWJ-67657 | C27H24FN3O | 215303-72-3 | Details |
AZD7624 | C27H30FN5O3 | 1095004-78-6 | Details |
Dilmapimod | C23H19F3N4O3 | 444606-18-2 | Details |
Talmapimod | C27H30ClFN4O3 | 309913-83-5 | Details |
BI-D1870 | C19H23F2N5O2 | 501437-28-1 | Details |
TC ASK 10 | C21H22ClN5O | 1005775-56-3 | Details |
Regorafenib | C21H15ClF4N4O3 | 755037-03-7 | Details |
Regorafenib monohydrate | C21H17ClF4N4O4 | 1019206-88-2 | Details |
GDC-0623 | C16H14FIN4O3 | 1168091-68-6 | Details |
JNK-IN-7 | C28H27N7O2 | 1408064-71-0 | Details |
XMD17-109 | C36H46N8O3 | 1435488-37-1 | Details |
DB07268 | C17H15N5O2 | 929007-72-7 | Details |
PF-4708671 | C19H21F3N6 | 1255517-76-0 | Details |
Ulixertinib | C21H22Cl2N4O2 | 869886-67-9 | Details |
Ulixertinib hydrochloride | C21H23Cl3N4O2 | 1956366-10-1 | Details |
CCT196969 | C27H24FN7O3 | 1163719-56-9 | Details |
DMX-5804 | C21H19N3O3 | 2306178-56-1 | Details |
JWG-071 | C34H44N8O3 | 2250323-50-1 | Details |
ETC-206 | C25H20N4O2 | 1464151-33-4 | Details |
SL327 | C16H12F3N3S | 305350-87-2 | Details |
SR-318 | C27H33N5O2 | 2413286-32-3 | Details |
CKI-7 free base | C11H12ClN3O2S | 120615-25-0 | Details |
Cobimetinib hemifumarate | C46H46F6I2N6O8 | 1369665-02-0 | Details |
Hypothemycin | C19H22O8 | 76958-67-3 | Details |
RRD-251 | C8H9Cl3N2S | 72214-67-6 | Details |
Tpl2 Kinase Inhibitor 1 | C21H14ClFN6 | 871307-18-5 | Details |
ERK1/2 inhibitor 2 | C29H31ClFN5O5 | 2095719-92-7 | Details |
AL 8697 | C21H21F3N4O | 1057394-06-5 | Details |
Product Total: Product Page: | ||||
17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 |